Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 4389257 | HCID 4389257 | — |
| Reactant | HCID 19104155 | HCID 19104155 | — |
| Reactant | HCID 59438561 | HCID 59438561 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 46222159 | HCID 46222159 | — |
| Product | HCID 66739439 | HCID 66739439 | — |
Reaction Steps
The title compound was prepared according to general procedure B described in Scheme 1. N-Isopropylindole (150 mg, 0.94 mmol) was converted to 2-(1-isopropyl-1H-indol-3-yl)-2-oxoacetyl chloride as described in example 1 and treated with a solution of 2-(1-(2-aminoethyl)piperidin-4-yl)ethanol (236 mg, 1.13 mmol), triethylamine (1.3 mL, 9.4 mmol) in DCM (2 mL) and stirred at RT for 14 h. The reaction mixture was then washed with sat. NaHCO3 (1×3 mL), H2O (1×3 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica chromatography (Biotage, 10-50% MeOH/DCM, 30 min.) to provide N-(2-(4-(2-hydroxyethyl)piperidin-1-yl)ethyl)-2-(1-isopropyl-1H-indol-3-yl)-2-oxoacetamide and further purified using reverse phase HPLC. The purified material was converted to the HCl salt to afford (27 mg, 7% yield): 1H NMR (400 MHz, CDCl3): δ 9.11 (s, 1H), 8.45 (m, 1H), 7.93 (t, 1H), 7.44 (m, 1H), 7.34 (m, 2H), 4.71 (m, 1H), 3.71 (t, 2H), 3.47 (q, 2H), 2.92 (d, 2H) 2.55 (t, 2H), 2.01 (t, 2H), 1.70 (d, 2H), 1.62 (d, 6H), 1.53 (q, 3H), 1.33 (t, 3H); MS (ESI) m/z: Calculated for C22H31N3O3: 385.2. Found: 385.5 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08114894B2 |
|---|
| Source dataset | uspto-grants-2012_02 |
|---|
| ORD ID | ord-8c27f7f5146243b285d124ed055665e2 |
|---|
| Source note | uspto-grants-2012_02 |
|---|